Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00033839 · ClinicalTrials.gov registry record · Phase 3
A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache
A Phase 3 study of Episodic Cluster Headache, sponsored by Winston Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 60
- Enrollment target
- 20
- Study locations
NCT00033839 is a Phase 3 study of Episodic Cluster Headache that has completed, run by Winston Laboratories. The registered enrollment target is 60 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT00033839, a Phase 3 study of Episodic Cluster Headache, has completed, sponsored by Winston Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 60 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).
Conditions Studied
Interventions
- DRUG Civamide (Zucapsaicin)
Study Locations (20)
California
- Northern California Headache Clinic - Mountain View
- San Francisco Clinical Research Center - San Francisco
- California Medical Clinic for Headache - Santa Monica
Arizona
- Valley Neurological Headache & Research Center - Phoenix
- Neurological Associates of Tucson - Tucson
Michigan
- Michigan Headache Pain & Neurological Institute - Ann Arbor
- Henry Ford Hospital Department of Neurology - Detroit
Missouri
- Mercy Health Research - Chesterfield
- Headache Care Center/Clinvest - Springfield
Ohio
- Cincinnati Headache Clinic - Cincinnati
- Cleveland Clinic Foundation - Cleveland
Connecticut
- New England Center for Headache, PC - Stamford
Florida
- Neurology Clinical Research, Inc. - Plantation
Georgia
- Neurology and Headache Specialists of Atlanta - Decatur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2002-01 |
| Est. Completion | 2003-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00033839
The ClinicalTrials.gov registry entry for NCT00033839 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Winston Laboratories, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Episodic Cluster Headache appearing as the primary indexed condition, and to 1 intervention - of which Civamide (Zucapsaicin) is the first listed.
NCT00033839 reports 20 study locations spanning 14 distinct geographic areas - top geographies include California, Arizona, Michigan.
Frequently Asked Questions
What is clinical trial NCT00033839 about?
NCT00033839 is a clinical study titled "A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache". This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).
What is the current status of trial NCT00033839?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 60 participants. The study started on 2002-01. Estimated completion is 2003-07.
What conditions does trial NCT00033839 study?
This clinical trial studies the following conditions: Episodic Cluster Headache.
What interventions are being tested in trial NCT00033839?
The interventions under investigation include: Civamide (Zucapsaicin) (DRUG).
Who is sponsoring clinical trial NCT00033839?
This trial is sponsored by Winston Laboratories, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00033839 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.